Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel silanization route for Decitabine intermediates offering high purity and industrial scalability without column chromatography.
Patent CN109824640B discloses a cost-effective 3-step synthesis of coumarin-based BRD4 inhibitors, offering reliable supply chain solutions for oncology drug development.
Patent CN102766081A reveals a green, solvent-free route for bis-indolylmethane derivatives using reusable ionic liquids, offering significant cost and supply chain advantages.
Patent CN114380748A details a continuous flow synthesis for Pazopanib intermediates, offering enhanced safety, purity, and scalable manufacturing capabilities for global supply chains.
Novel L-alanine catalyzed route improves yield and purity for KRAS G12C inhibitor intermediates, offering cost-effective scale-up solutions.
Novel synthesis of peptidomimetic aminopeptidase inhibitors via thiadiazole coupling. Offers cost-effective routes for oncology drug development.
Novel synthesis of 5,6-hydroxyl substituted brazilin analog via Prins/Friedel-Crafts reaction. Offers cost-effective route for bladder cancer drug intermediates.
Advanced synthesis of Cyclophosphamide via patent CN109535201B. Offers high yield, mild conditions, and cost reduction in API manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Discover advanced synthesis for RORγ modulators via patent CN114096533B. Enhance supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN101792416A details a cost-effective Bosutinib synthesis using vanillic acid, offering mild conditions and high purity for reliable pharmaceutical intermediate supply chains.
Novel 4-step route for Tomivosertib offers high purity and simplified processing for cost-effective API manufacturing and supply chain stability.
Patent CN111302997A reveals a streamlined one-pot method for Raatinib intermediates, offering significant cost and waste reduction for API manufacturing.
Novel synthesis of Abiraterone Acetate via CN107176965A patent. Cost-effective route using pregnadienolone acetate for reliable pharmaceutical intermediate supply chain.
Patent CN106243018B reveals nickel-catalyzed route for PIM447 intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains globally.
Novel mild method for Imatinib production avoiding toxic reagents. High yield, scalable process for pharmaceutical intermediates ensuring supply chain stability.
Novel azabicyclic derivatives targeting EGFR T790M mutations offer high selectivity and reduced toxicity, enabling cost-effective API manufacturing and reliable supply chain solutions for oncology drugs.
Patent CN114621985B reveals enzymatic synthesis breakthrough. Delivers high purity and supply chain reliability for global pharmaceutical intermediate procurement strategies.
Patent CN101016293A details a catalyst-free route for imatinib intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Novel Boc-protection strategy for high-purity Raltitrexed intermediate. Reduces side reactions, improves yield, ensures supply chain stability for pharma manufacturing.
Patent CN1761644A details scalable synthesis of 4-amino-2-butenoyl chloride for kinase inhibitors. Discover cost-effective manufacturing and high-purity supply chain solutions.